Case number 1:19-cv-00318
Merck Sharp & Dohme Corp. v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Nov 17, 2020 | 190 | Memorandum Opinion (25) Docket Text: MEMORANDUM OPINION providing claim construction for various terms in U.S. Patent Nos. 7,326,708 and 8,414,921. Signed by Judge Richard G. Andrews on 11/17/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Nov 12, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The redacted document filed at D.I. 187 has been removed from the docket as it was not linked to the sealed filing it is related to. (nms) |
| Nov 12, 2020 | 187 | Redacted Document (27) Docket Text: REDACTED VERSION of [184] Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms). |
| Nov 12, 2020 | 188 | Redacted Document (29) Docket Text: REDACTED VERSION of [181] Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms). |
| Nov 12, 2020 | 189 | Redacted Document (20) Docket Text: REDACTED VERSION of [182] Notice of Service, by Merck Sharp & Dohme Corp.. (Joyce, Alexandra) Modified on 11/13/2020 (nms). Modified on 11/16/2020 (nms). |
| Nov 10, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per D.I. [186]. (nms) |
| Nov 10, 2020 | 185 | Proposed Consent Judgment (4) Docket Text: PROPOSED Consent Judgment, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 11/10/2020 (nms). |
| Nov 10, 2020 | 186 | Order (4) Docket Text: ORDER Granting (185 in 19-cv-318-RGA; 296 in 19-md-2902-RGA) Proposed Consent Judgment. Signed by Judge Richard G. Andrews on 11/10/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Nov 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (32 in 20-cv-847-RGA; 48 in 20-cv-776-RGA; 293 in 19-md-2902-RGA; 116 in 19-cv-314-RGA; 31 in 20-cv-949-RGA; 126 in 19-cv-313-RGA; 121 in 19-cv-319-RGA; 35 in 20-cv-815-RGA; 30 in 20-cv-1099-RGA; 16 in 20-cv-1227-RGA; 183 in 19-cv-318-RGA; 124 in 19-cv-311-RGA; 123 in 19-cv-347-RGA; 149 in 19-cv-1489-RGA; 149 in 19-cv-317-RGA; 34 in 20-cv-749-RGA; 120 in 19-cv-312-RGA) MOTION for Pro Hac Vice Appearance of Attorney Sarahi Uribe. Signed by Judge Richard G. Andrews on 11/6/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Nov 6, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sarahi Uribe for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al. (kmd) |
| Nov 6, 2020 | 183 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Sarahi Uribe - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Sarahi Uribe)(Silver, Daniel) |
| Nov 6, 2020 | 183 | Certification for Sarahi Uribe (1) |
| Nov 4, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (123 in 19-cv-313-RGA; 146 in 19-cv-317-RGA; 45 in 19-cv-00347-RGA; 119 in 19-cv-311-RGA; 283 in 19-md-2902-RGA; 117 in 19-cv-312-RGA; 180 in 19-cv-318-RGA; 28 in 20-cv-949-RGA; 27 in 20-cv-1099-RGA; 31 in 20-cv-749-RGA; 28 in 20-cv-815-RGA; 118 in 19-cv-00319-RGA; 29 in 20-cv-847-RGA; 113 in 19-cv-314-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 11/4/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Nov 4, 2020 | 180 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jihad Komis - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Jihad Komis)(Silver, Daniel) |
| Nov 4, 2020 | 180 | Certification for Jihad Komis (1) |
| Nov 2, 2020 | 179 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, from Dominick T. Gattuso, Esq., regarding Merck's letter dated 10/30/2020. (Gattuso, Dominick) Modified on 11/3/2020 (nms). |
| Oct 30, 2020 | 178 | Letter (1) Docket Text: Letter to The Honorable Richard G. Andrews from Daniel M. Silver regarding Certificate of Correction. (Silver, Daniel) |
| Oct 22, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The redacted filings (D.I. 113 in 19cv311-RGA; D.I. 112 in 19cv312-RGA; D.I. 116 in 19cv313-RGA; D.I. 107 in 19cv314-RGA; D.I. 141 in 19cv317-RGA; D.I. 175 in 19cv318-RGA; D.I. 112 in 19cv319-RGA; D.I. 115 in 19cv347-RGA; D.I. 139 in 19cv1489-RGA; D.I. 268 in 19md2902-RGA; D.I. 41 in 20cv776) have be all been removed as they were incorrectly linked to the sealed filings they related to. Associated Cases: 1:20-cv-00776-RGA et al.(nms) |
| Oct 22, 2020 | 173 | Redacted Document (30) Docket Text: REDACTED VERSION of [171] Sealed Transcript. (nms) |
| Oct 22, 2020 | 174 | Notice of Service (13) Docket Text: NOTICE OF SERVICE of (1) Second Set of Interrogaotries from Plaintiff Merck Sharp & Dohme to Defendants and (2) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 22, 2020 | 176 | Redacted Document (7) Docket Text: REDACTED VERSION of [167] Renewed Motion to Redact Transcript and for a Further Extension of Time to File Redactions, by Biocon Limited. (Attachments: # (1) Proposed Order, # (2) Exhibits A-C)(Mowery, Katharine) Modified on 10/22/2020 (nms). |
| Oct 22, 2020 | 176 | Text of Proposed Order (2) |
| Oct 22, 2020 | 176 | Exhibit A-C (70) |
| Oct 22, 2020 | 177 | Redacted Document (5) Docket Text: REDACTED VERSION of [158] Unopposed Motion to Redact Transcript, by Biocon Limited. (Attachments: # (1) Proposed Order, # (2) Exhibits A-C)(Mowery, Katharine) Modified on 10/22/2020 (nms). |
| Oct 22, 2020 | 177 | Text of Proposed Order (2) |
| Oct 22, 2020 | 177 | Exhibit A-C (69) |
| Oct 21, 2020 | 169 | Memorandum and Order (2) Docket Text: MEMORANDUM ORDER regarding unopposed motion to redact portions of the transcript of a discovery dispute conference. A separate order granting the motion will be filed. Signed by Judge Richard G. Andrews on 10/21/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Oct 21, 2020 | 170 | Order (2) Docket Text: ORDER Granting (258 in 19-md-2902-RGA) Unopposed Motion to Redact Transcript and for a Further Extension of Time to to File Redactions. Signed by Judge Richard G. Andrews on 10/21/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Oct 21, 2020 | 172 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Invalidity Contentions filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Oct 19, 2020 | 168 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) Regarding the 072 Patent filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Oct 16, 2020 | 166 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. Regarding U.S. Patent No. 7,326,708; (2) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,612,072; (3) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. Regarding U.S. Patent 8,414,921; and (4) Supplemental Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Oct 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (165 in 19-cv-318-RGA: 129 in 19-cv-1489-RGA; 103 in 19-cv-319-RGA; 99 in 19-cv-314-RGA; 107 in 19-cv-313-RGA; 251 in 19-md-2902-RGA; 107 in 19-cv-347-RGA; 131 in 19-cv-317-RGA; 104 in 19-cv-312-RGA; 102 in 19-cv-311-RGA) STIPULATION TO EXTEND TIME to Serve Supplemental Invalidity and Infringement Contentions to October 21, 2020. Signed by Judge Richard G. Andrews on 10/15/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Oct 14, 2020 | 165 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME to Serve Supplemental Invalidity and Infringement Contentions to October 21, 2020 - filed by Sun Pharmaceutical Industries Ltd.. (Gaza, Anne) |
| Oct 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (250 in 19-md-2902-RGA; 106 in 19-cv-347-RGA; 106 in 19-cv-313-RGA; 102 in 19-cv-319-RGA, 101 in 19-cv-311-RGA; 164 in 19-cv-318-RGA; 130 in 19-cv-317-RGA; 128 in 19-cv-1489-RGA; 98 in 19-cv-314-RGA; 103 in 19-cv-312-RGA) Unopposed Motion for Extension of Time to File Redactions. Signed by Judge Richard G. Andrews on 10/13/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Oct 9, 2020 | 162 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Third Supplemental Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 9, 2020 | 163 | Notice to Take Deposition (16) Docket Text: NOTICE to Take Deposition of Plaintiff Merck Sharp & Dohme Corp. on mutually agreed upon date filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) Modified on 10/13/2020 (nms). Modified on 10/13/2020 (nms). |
| Oct 9, 2020 | 164 | Motion for Extension of Time (2) Docket Text: Unopposed Motion for Extension of Time to File Redactions - filed by Biocon Limited. (Attachments: # (1) Proposed Order)(Mowery, Katharine) Modified on 10/13/2020 (nms). |
| Oct 9, 2020 | 164 | Text of Proposed Order (1) |
| Oct 6, 2020 | 161 | Notice (Other) (2) Docket Text: Amended NOTICE of Deposition of Nurit Perlman by Merck Sharp & Dohme Corp. (Silver, Daniel) |
| Oct 5, 2020 | 160 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants' Second Set of Joint Interrogatories (Nos. 11-13) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Oct 2, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The motion to redact (see C.A. 19-311-RGA D.I. [96]) is DENIED. The redactions are extensive, and the request to redact is unsupported by any statement under oath. I do not think the motion meets the requirements of Avandia Marketing. Ordered by Judge Richard G. Andrews on 10/2/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Sep 29, 2020 | 157 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiff's Responses and Objections to Defendants' Notice of Deposition Under Rule 30(b)(6) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Sep 25, 2020 | 155 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Claim Construction by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Sep 25, 2020 | 156 | Order (4) Docket Text: SO ORDERED Granting (121 in 19-cv-317-RGA; 155 in 19-cv-318-RGA; 225 in 19-md-2902-RGA) Stipulation and Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 9/25/2020. Associated Cases: 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Sep 23, 2020 | 154 | Notice of Service (11) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Second Supplement Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Sep 18, 2020 | 152 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. and Watson Laboratories, Inc.s Claim Construction Issue Identification [CONFIDENTIAL] filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) |
| Sep 18, 2020 | 153 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Sep 11, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The redacted document filed at D.I. 151 has been removed from the docket. The filing was not appropriately linked to the sealed filing it was in relation to. (nms) |
| Sep 11, 2020 | 151 | Redacted Document (2) Docket Text: REDACTED VERSION of [142] Letter, by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) Modified on 9/11/2020 (nms). |
| Sep 11, 2020 | 151 | Exhibit Certificate of Service (4) |
| Sep 10, 2020 | N/A | Discovery Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Discovery Conference held on 9/10/2020. Counsel for Plaintiff: D. Silver. Counsel for Defendants: S. Fineman. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02902-RGA et al.(lak) |
| Sep 9, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The redacted document filed at D.I. 144 has been removed from the docket. The filing was not appropriately linked to the sealed filing it was in relation to. (nms) |
| Sep 9, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re Stipulation and Order to Extend Time for Redactions. Signed by Judge Richard G. Andrews on 9/9/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Sep 9, 2020 | 146 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Second Supplemental Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-6) [HIGHLY CONFIDENTIAL] filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Sep 9, 2020 | 147 | Redacted Document (14) Docket Text: REDACTED VERSION of [138] Declaration, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/9/2020 (nms). |
| Sep 9, 2020 | 148 | Notice (Other) (2) Docket Text: NOTICE of Depositions by Merck Sharp & Dohme Corp. (Silver, Daniel) |
| Sep 9, 2020 | 149 | Redacted Document (30) Docket Text: REDACTED VERSION of [134] Letter, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 9/10/2020 (nms). |
| Sep 9, 2020 | 150 | Redacted Document (4) Docket Text: REDACTED VERSION of [139] Letter, by Biocon Limited. (Attachments: # (1) Exhibits 1-2, # (2) Proposed Order)(Mowery, Katharine) Modified on 9/10/2020 (nms). |
| Sep 9, 2020 | 150 | Exhibit 1-2 (5) |
| Sep 9, 2020 | 150 | Text of Proposed Order (1) |
| Sep 8, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Calvin E. Wingfield, Jr. for Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Sandoz Inc., added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00312-RGA, 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(kmd) |
| Sep 8, 2020 | 143 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Watson Laboratories, Inc. and Teva Pharmaceuticals USA, Inc.s Initial Invalidity Contentions filed by Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) |
| Sep 8, 2020 | 145 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for submission of a redacted public version of Plaintiff's August 31, 2020 Opening Discovery Letter Brief to September 9, 2020 - filed by Biocon Limited. (Mowery, Katharine) |
| Sep 4, 2020 | 141 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Second Set of Joint Interrogatories to Plaintiff (Nos. 11-13) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Sep 3, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (140 in 19-cv-318-RGA; 86 in 19-cv-312-RGA; 198 in 19-md-2902-RGA; 106 in 19-cv-317-RGA) MOTION for Pro Hac Vice Appearance of Attorney Calvin E. Wingfield Jr., filed by Teva Pharmaceutical Industries, Ltd., Sandoz Inc., Watson Laboratories, Inc.. Signed by Judge Richard G. Andrews on 9/3/2020. Associated Cases: 1:19-cv-00312-RGA, 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Sep 3, 2020 | 140 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Calvin E. Wingfield Jr. - filed by Teva Pharmaceutical Industries, Ltd., Watson Laboratories, Inc., Sandoz Inc.. (Gattuso, Dominick) |
| Sep 1, 2020 | 135 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Notice of Deposition of Plaintiff Under Federal Rule of Civil Procedure 30(b)(6) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Sep 1, 2020 | 136 | Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Ivan Lee on November 4, 2020 filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Aug 31, 2020 | 133 | Answer to Counterclaim (13) Docket Text: ANSWER to [113] Answer to Amended Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Aug 28, 2020 | 129 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Kyle A. Fliszar, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms). |
| Aug 28, 2020 | 130 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Soumojeet Ghosh, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms). |
| Aug 28, 2020 | 131 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Laman Alani, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms). |
| Aug 28, 2020 | 132 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Monica Tijerinac, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/28/2020 (nms). |
| Aug 27, 2020 | 124 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Joseph D. Armstrong, III, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms). |
| Aug 27, 2020 | 125 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Shane W. Krska, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms). |
| Aug 27, 2020 | 126 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Thorsten Rosner, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms). |
| Aug 27, 2020 | 127 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Yongkui Sun, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms). |
| Aug 27, 2020 | 128 | Notice (Other) (30) Docket Text: NOTICE of Subpoena Duces Tecum And Subpoena To Testify At A Deposition Directed To Nelo R. Rivera, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 8/27/2020 (nms). |
| Aug 21, 2020 | 123 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants Fourth Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 158-161) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Aug 20, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The parties have advised that a dispute has arisen requiring judicial attention. The Court will hold a discovery conference on 9/10/2020, at 10:00 AM. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Court's form Patent Scheduling Order (Revised 12/19/2019). The hearing will be held using Skype for business. A joint email with the email addresses for all those participating in the conference shall be due to the Court's Case Manager by 4:00 PM on 9/3/2020. Ordered by Judge Richard G. Andrews on 8/20/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Aug 19, 2020 | 121 | Letter (2) Docket Text: Letter to The Honorable Richard G. Andrews, dated August 19, 2020 from Fred Cottrell, regarding opposition to notice of subsequent development. (Cottrell, Frederick) Modified on 8/19/2020 (nms). |
| Aug 18, 2020 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Markman/Status Conference held on 8/18/2020. Counsel for Plaintiff: D. Silver. Counsel for Defendant's: D. Gattuso, J. Philips, F. Cottrell, A. Gaza, S. Fineman. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-md-02902-RGA et al.(lak) |
| Aug 17, 2020 | 117 | Order (1) Docket Text: TENTATIVE MARKMAN ORDER (see Order for details). Signed by Judge Richard G. Andrews on 8/17/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Aug 17, 2020 | 118 | Order (4) Docket Text: SO ORDERED Granting Stipulation and Proposed Order as to Venue for Discovery Dispute Regarding Enforcement of Subpoena to Biocon Limited. Signed by Judge Richard G. Andrews on 8/17/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Aug 17, 2020 | 119 | Redacted Document (75) Docket Text: REDACTED VERSION of [113] Answer to Amended Complaint, Counterclaim, by Teva Pharmaceuticals USA, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) Modified on 8/17/2020 (nms). |
| Aug 17, 2020 | 119 | Certificate of Service (1) |
| Aug 17, 2020 | 120 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s Objections and Responses to Plaintiffs Notice of Deposition Pursuant to Fed. R. Civ. P. 30(B)(6) [CONFIDENTIAL] filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Aug 14, 2020 | 115 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order as to Venue for Discovery Dispute Regarding Enforcement of Subpoena to Biocon Limited by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Aug 14, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The court directs that at the Markman hearing on August 18 the terms surfactant and sitagliptin be argued first, followed by the disputed terms of the 708 patent. Ordered by Judge Richard G. Andrews on 8/14/2020. Associated Cases: 1:19-cv-00311-RGA et al.(nms) |
| Aug 13, 2020 | 114 | Notice (Other) (30) Docket Text: NOTICE of Subsequent Development by Merck Sharp & Dohme Corp. (Silver, Daniel) |
| Aug 7, 2020 | N/A | Remark (0) Docket Text: Remark: The dial-in information for the August 18, 2020 Markman/Status Conference is as follows: 1-202-503-1666 Conference ID: 14483986#. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Aug 7, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Date corrected to August 18, 2020 in the remark above regarding the dial-in information for the Markman/Status conference. Associated Cases: 1:19-md-02902-RGA et al. (lak) |
| Aug 6, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (156 in 19-md-2902-RGA; 111 in 19-cv-318-RGA) STIPULATION and Order to Extend Time to move, answer, or otherwise respond to the Second Amended Complaint to August 10, 2020. Signed by Judge Richard G. Andrews on 8/6/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Aug 6, 2020 | 111 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Teva to move, answer, or otherwise respond to the Second Amended Complaint to August 10, 2020 - filed by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) |
| Aug 6, 2020 | 112 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants Third Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 118-157) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Aug 5, 2020 | 110 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,612,072 filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Aug 3, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Markman hearing scheduled for August 18, 2020, will be held using Skype for business. A joint email with the email addresses for all those participating in the hearing shall be due to the Court's Case Manager by 4:00 PM on 8/7/2020. Ordered by Judge Richard G. Andrews on 8/3/2020. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Jul 28, 2020 | 108 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Privilege Log filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Jul 23, 2020 | 106 | Redacted Document (30) Docket Text: REDACTED VERSION of [96] Stipulation, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/27/2020 (nms). |
| Jul 23, 2020 | 107 | Redacted Document (30) Docket Text: REDACTED VERSION of [98] Amended Complaint, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/27/2020 (nms). |
| Jul 22, 2020 | 103 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiff's Rule 26 and Paragraph 3 Initial Disclosures Regarding Certain Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jul 22, 2020 | 104 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Fourth Set of Joint Requests for the Production of Documents and Things (Nos. 158-161) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Jul 22, 2020 | 105 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s Second Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Jul 17, 2020 | 99 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708 ;8,414,921 ;7,468,459 ;7,612,072 . (Silver, Daniel) |
| Jul 17, 2020 | 100 | Joint Claim Construction Brief (30) Docket Text: Joint Claim Construction Brief, filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 7/20/2020 (nms). |
| Jul 17, 2020 | 101 | Appendix (7) Docket Text: Joint Appendix, Volume 1, by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibits 1-12, # (2) Exhibits 13-17, # (3) Exhibits 18-24)(Silver, Daniel) Modified on 7/20/2020 (nms). |
| Jul 17, 2020 | 101 | Exhibit 1-12 (235) |
| Jul 17, 2020 | 101 | Exhibit 13-17 (249) |
| Jul 17, 2020 | 101 | Exhibit 18-24 (210) |
| Jul 17, 2020 | 102 | Appendix (7) Docket Text: Joint Appendix, Volume 2, by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibits 25-45)(Silver, Daniel) Modified on 7/20/2020 (nms). |
| Jul 17, 2020 | 102 | Exhibit 25-45 (501) |
| Jul 16, 2020 | 95 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) to Teva filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jul 13, 2020 | 94 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) |
| Jul 8, 2020 | 93 | Notice (Other) (2) Docket Text: NOTICE of of Subpoenas by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc. (Attachments: # (1) Exhibit A - F)(Fineman, Steven) |
| Jul 8, 2020 | 93 | Exhibit A - F (90) |
| Jul 7, 2020 | 92 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Defendants Third Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 118-157) filed by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) |
| Jul 2, 2020 | 91 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.s First Supplemental Responses and Objections to Plaintiffs First Set of Interrogatories (Nos. 1-6) [Highly Confidential] filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Jun 29, 2020 | 90 | SO ORDERED (6) Docket Text: SO ORDERED, re (56 in 19-cv-314-RGA; 58 in 19-cv-312-RGA; 62 in 19-cv-310-RGA; 61 in 19-cv-311-RGA; 62 in 19-cv-313-RGA; 119 in 19-md-02902-RGA; 64 in 19-cv-347-RGA; 63 in 19-cv-317-RGA; 58 in 19-cv-319-RGA; 87 in 19-cv-1489-RGA; 89 in 19-cv-318-RGA) Stipulation and Order. Signed by Judge Richard G. Andrews on 6/29/2020. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Jun 26, 2020 | 89 | Stipulation (6) Docket Text: STIPULATION and Proposed Order, by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) Modified on 6/29/2020 (nms). |
| Jun 8, 2020 | 87 | Notice of Service (9) Docket Text: NOTICE OF SERVICE of Merck Sharp & Dohme Corp.'s Reply Markman Brief filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jun 8, 2020 | 88 | Notice of Service (10) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Responses and Objections to Defendants' Second Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 108-117) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| May 18, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re MOTION for Pro Hac Vice Appearance of Attorney Elise M. Baumgarten, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 5/18/2020. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| May 18, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Elise M. Baumgarten for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-md-02902-RGA et al.(kmd) |
| May 14, 2020 | 86 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elise M. Baumgarten - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Elise M. Baumgarten)(Silver, Daniel) |
| May 14, 2020 | 86 | Certification for Elise M. Baumgarten (1) |
| May 11, 2020 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The pdf for the Notice of Service filed on May 8, 2020, has been replaced per counsel's request. The filing has been corrected to reflect the "Second Set" of requests were being served, not the "First Set." Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| May 8, 2020 | 85 | Notice of Service (8) Docket Text: NOTICE OF SERVICE of Second Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 108-117), filed by Sandoz Inc., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc..(Gattuso, Dominick) (Main Document 57 replaced on 5/11/2020) (nms). Modified on 5/11/2020 (nms). |
| May 6, 2020 | 84 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs Responses and Objections to Tevas First Set of Requests for the Production of Documents and Things (Nos. 1-79) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| May 5, 2020 | 83 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Objections and Responses to the Second Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp., filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) Modified on 5/6/2020 (nms). |
| May 4, 2020 | 82 | Notice of Service (5) Docket Text: NOTICE OF SERVICE of Defendants' Claim Construction Brief filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Apr 30, 2020 | 80 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Claim Construction by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Apr 30, 2020 | 81 | Order (3) Docket Text: SO ORDERED Granting (104 in 19-md-02902-RGA; 80 in 19-cv-318-RGA) Stipulation and Proposed Order Regarding Claim Construction. Signed by Judge Richard G. Andrews on 4/30/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Apr 27, 2020 | 78 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Apr 27, 2020 | 79 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Claim Construction Issue Identification filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Apr 24, 2020 | 77 | Notice of Service (14) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s First Supplemental Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Apr 21, 2020 | 76 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. 's Initial Invalidity Contentions filed by Teva Pharmaceutical Industries Ltd..(Gattuso, Dominick) |
| Apr 8, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (75 in 19-cv-318-RGA; 95 in 19-md-2902-RGA) STIPULATION and Proposed Order. Signed by Judge Richard G. Andrews on 4/8/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Apr 8, 2020 | 75 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION and Proposed Order - filed by Teva Pharmaceutical Industries Ltd.. (Gattuso, Dominick) Modified on 4/8/2020 (nms). |
| Apr 6, 2020 | 74 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s First Set of Requests for the Production of Documents and Things directed to Plaintiff (Nos. 1-79) filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Apr 3, 2020 | 73 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Second Set of Requests for Production from Plaintiff Merck Sharp & Dohme Corp. to Defendants filed by Merck Sharp & Dohme Corp..(Joyce, Alexandra) |
| Apr 1, 2020 | 72 | Redacted Document (14) Docket Text: REDACTED VERSION of [71] Answer to Counterclaim, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 4/1/2020 (nms). |
| Mar 20, 2020 | 70 | Notice (Other) (12) Docket Text: NOTICE of Service of Plaintiff Merck Sharp & Dohme Corp.'s Opening Markman Brief by Merck Sharp & Dohme Corp. (Silver, Daniel) |
| Mar 16, 2020 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 7,468,459 filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Mar 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (80 in 19-md-2902-RGA; 66 in 19-cv-318-RGA) Stipulation and Proposed Order Regarding Joint Claim Construction Chart. Signed by Judge Richard G. Andrews on 3/9/2020. Associated Cases: 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Mar 10, 2020 | 67 | Redacted Document (64) Docket Text: REDACTED VERSION of 65Answer to Amended Complaint, and Counterclaim, by Teva Pharmaceuticals USA, Inc.. (Attachments: # (1) Certificate of Service)(Gattuso, Dominick) Modified on 3/12/2020 (nms). Modified on 3/12/2020 (nms). |
| Mar 10, 2020 | 67 | Certificate of Service (1) |
| Mar 10, 2020 | 68 | Redacted Document (20) Docket Text: REDACTED VERSION of [63] Notice of Service, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 3/12/2020 (nms). |
| Mar 9, 2020 | 66 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Joint Claim Construction Chart by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Mar 3, 2020 | 64 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Mar 2, 2020 | 62 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. 's Identification of Proposed Claim Terms of U.S. Patents No.8,414,921 for Construction filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Feb 28, 2020 | 60 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiff's Rule 26 and Paragraph 3 Initial Disclosures regarding the '921 and '459 Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Feb 28, 2020 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 of the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals USA, Inc., Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Feb 25, 2020 | 58 | Redacted Document (30) Docket Text: REDACTED VERSION of [53] Stipulation, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 2/25/2020 (nms). |
| Feb 25, 2020 | 59 | Redacted Document (30) Docket Text: REDACTED VERSION of [56] Amended Complaint, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 2/26/2020 (nms). |
| Feb 24, 2020 | N/A | Redaction Notice (0) Docket Text: REDACTION NOTICE: In accordance with section G of the Administrative Procedures Governing Filing and Service by Electronic Means, redacted versions of sealed documents shall be filed electronically within 7 days of the filing of the sealed document. The records of this case do not reflect the filing of a redacted version of DI #[53]. (nms) |
| Feb 24, 2020 | 57 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. for U.S. Patent No. 8,414,921 filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Feb 14, 2020 | 54 | Claim Construction Chart (13) Docket Text: Joint Claim Construction Chart, by Merck Sharp & Dohme Corp.. (Attachments: # (1) Exhibits A-J)(Silver, Daniel) Modified on 2/18/2020 (nms). |
| Feb 14, 2020 | 54 | Exhibits A - J (242) |
| Feb 11, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sarah J Fischer for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Feb 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (52 in 19-cv-318-RGA; 53 in 19-md-2902-RGA; 51 in 19-cv-317-RGA; 46 in 19-cv-312-RGA) MOTION for Pro Hac Vice Appearance of Attorney Shaobo Zhu and Sarah J. Fischer, filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals Industries, Ltd., Sandoz Inc., Watson Laboratories, Inc., Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 2/10/2020. Associated Cases: 1:19-cv-00312-RGA, 1:19-cv-00317-RGA, 1:19-cv-00318-RGA, 1:19-md-02902-RGA(nms) |
| Feb 10, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Shaobo Zhu for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Feb 10, 2020 | 52 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shaobo Zhu and Sarah J. Fischer - filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc., Teva Pharmaceutical Industries Ltd.. (Gattuso, Dominick) |
| Jan 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (44 in 19-cv-311-RGA; 51 in 19-cv-318-RGA; 45 in 19-cv-312-RGA, 43 in 19-cv-320-RGA; 44 in 19-cv-314-RGA; 44 in 19-cv-316-RGA: 50 in 19-cv-317-RGA, 50 in 19-cv-313-RGA; 46 in 19-cv-319-RGA; 47 in 19-cv-872-RGA; 43 in 19-cv-321-RGA, 48 in 19-md-2902-RGA; 48 in 19-cv-347-RGA; 74 in 19-cv-1489-RGA; 48 in 19-cv-310-RGA) STIPULATION and Proposed Order to Amend Scheduling Order. Signed by Judge Richard G. Andrews on 1/30/2020. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Jan 30, 2020 | 51 | Stipulation to EXTEND Time (8) Docket Text: STIPULATION and Proposed Order to Amend Scheduling Order - filed by Teva Pharmaceutical Industries Ltd., Sandoz Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) Modified on 1/30/2020 (nms). |
| Jan 24, 2020 | 49 | Notice of Service (12) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Claim Construction Issue Identification filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jan 24, 2020 | 50 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Defendants' Claim Terms for Construction and Proposed Constructions filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Nov 14, 2019 | 48 | Notice of Service (15) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants First Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 1-107) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 25, 2019 | 47 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Defendants' Initial Invalidity Contentions filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Oct 17, 2019 | 46 | Notice of Service (12) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.s Responses and Objections to Defendants First Set of Joint Interrogatories (Nos. 1-10) filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Oct 1, 2019 | 45 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Requests for the Production of Documents and Things to Plaintiff (Nos. 1-107) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Sep 30, 2019 | 44 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-6) and Objections and Responses to Plaintiff's First Set of Requests for Production of Documents (Nos. 1-78) filed by In re: Sitagliptin Phosphate ('708 & '921) Patent Litigation, Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Sep 23, 2019 | 43 | Notice of Service (6) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Joint Interrogatories to Plaintiff (Nos. 1-10) filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Mowery, Katharine) |
| Sep 13, 2019 | 42 | Notice of Service (16) Docket Text: NOTICE OF SERVICE of Initial Infringement Contentions of Plaintiff Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Aug 30, 2019 | 41 | Notice of Service (20) Docket Text: NOTICE OF SERVICE of Plaintiff Merck Sharp & Dohme Corp.'s First Sets of Interrogatories and First Sets of Requests for Production to Defendants filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Aug 28, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (32 in 19-cv-316-RGA, 18 in 19-md-2902-RGA, 40 in 19-cv-318-RGA, 39 in 19-cv-313-RGA, 32 in 19-cv-320-RGA, 33 in 19-cv-319-RGA, 33 in 19-cv-314-RGA, 32 in 19-cv-321-RGA, 35 in 19-cv-347-RGA, 32 in 19-cv-311-RGA, 37 in 19-cv-310-RGA, 34 in 19-cv-312-RGA, 39 in 19-cv-317-RGA, 29 in 19-cv-872-RGA) STIPULATION and Proposed Order to Extend Time. Signed by Judge Richard G. Andrews on 8/28/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Aug 27, 2019 | 40 | Stipulation to EXTEND Time (8) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/27/2019 (nms). |
| Aug 21, 2019 | 39 | Order (30) Docket Text: SO ORDERED regarding Stipulated Protective Order. Signed by Judge Richard G. Andrews on 8/20/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Aug 20, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (55 in 19-cv-1489-RGA, 32 in 19-cv-347-RGA, 30 in 19-cv-319-RGA, 29 in 19-cv-320-RGA, 29 in 19-cv-321-RGA, 36 in 19-cv-313-RGA, 34 in 19-cv-310-RGA, 8 in 19-md-2902-RGA, 29 in 19-cv-316-RGA, 30 in 19-cv-314-RGA, 37 in 19-cv-318-RGA, 24 in 19-cv-872-RGA, 31 in 19-cv-312-RGA, 29 in 19-cv-311-RGA, 36 in 19-cv-317-RGA) STIPULATION TO EXTEND TIME Proposed Protective Order to August 19, 2019. Signed by Judge Richard G. Andrews on 8/15/2019. Associated Cases: 1:19-md-02902-RGA et al.(nms) |
| Aug 19, 2019 | 38 | Proposed Order (30) Docket Text: PROPOSED Stipulated Protective Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 8/20/2019 (nms). |
| Aug 15, 2019 | 37 | Stipulation to EXTEND Time (8) Docket Text: STIPULATION TO EXTEND TIME Proposed Protective Order to August 19, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Aug 8, 2019 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:19-md-02902-RGA et al.(amf) |
| Aug 8, 2019 | 35 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on Multi-District Litigation on 8/8/2019 - Associated Cases: 1:19-md-02902-RGA et al.(amf) |
| Aug 8, 2019 | 36 | Remark - MDL Notice to Counsel (1) Docket Text: NOTICE TO COUNSEL: MDL No. 1:19-md-2902 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents may use the attached form to register for a CM/ECF login and password. Please see the docket for further entries. Associated Cases: 1:19-md-02902-RGA et al.(amf) |
| Aug 7, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (33 in 19-cv-313-RGA, 26 in 19-cv-311-RGA, 26 in 19-cv-321-RGA, 34 in 19-cv-318-RGA, 28 in 19-cv-312-RGA, 27 in 19-cv-314-RGA, 29 in 19-cv-347-RGA, 27 in 19-cv-319-RGA, 20 in 19-cv-872-RGA, 31 in 19-cv-310-RGA, 26 in 19-cv-320-RGA, 33 in 19-cv-317-RGA, 26 in 19-cv-316-RGA) STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Protective Order to August 15, 2019. Signed by Judge Richard G. Andrews on 8/7/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Aug 6, 2019 | 34 | Stipulation to EXTEND Time (8) Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Protective Order to August 15, 2019 - filed by Merck Sharp & Dohme Corp.. (Silver, Daniel) |
| Aug 1, 2019 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc.'s Core Technical Documents filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Jul 31, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re STIPULATION TO EXTEND TIME to submit proposed Protective Order to August 7, 2019. Signed by Judge Richard G. Andrews on 7/31/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Jul 31, 2019 | 32 | Stipulation to EXTEND Time (8) Docket Text: STIPULATION TO EXTEND TIME Proposed Protective Order to August 7, 2019 - filed by Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA, Inc., Watson Laboratories, Inc.. (Gattuso, Dominick) |
| Jul 26, 2019 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and Paragraph 3 filed by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) |
| Jul 26, 2019 | 31 | Notice of Service (15) Docket Text: NOTICE OF SERVICE of Plaintiff's Initial Dislcosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure and Paragraph 3 of the Delaware Default Standard for Discovery filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jul 19, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (23 in 19-cv-314-RGA, 15 in 19-cv-872-RGA, 29 in 19-cv-313-RGA, 29 in 19-cv-318-RGA, 22 in 19-cv-316-RGA, 21 in 19-cv-321-RGA, 28 in 19-cv-317-RGA, 21 in 19-cv-311-RGA, 23 in 19-cv-312-RGA, 24 in 19-cv-347-RGA, 22 in 19-cv-320-RGA, 26 in 19-cv-310-RGA, 22 in 19-cv-319-RGA) STIPULATION TO EXTEND TIME for submission of a proposed protective order to July 31, 2019. Signed by Judge Richard G. Andrews on 7/19/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Jul 18, 2019 | 29 | Stipulation to EXTEND Time (8) Docket Text: STIPULATION TO EXTEND TIME for submission of a proposed protective order to July 31, 2019 - filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Mowery, Katharine) |
| Jul 9, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re STIPULATION TO EXTEND TIME to Exchange of Initial Disclosures pursuant to Rule 26(a), and Paragraph 3 disclosures to July 26, 2019. Signed by Judge Richard G. Andrews on 7/9/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Jul 8, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00310-RGA et al.(cak) |
| Jul 8, 2019 | 28 | Stipulation to EXTEND Time (8) Docket Text: STIPULATION TO EXTEND TIME Exchange of (i) Initial Disclosures pursuant to Rule 26(a); (ii) Paragraph 3 disclosures to July 26, 2019 - filed by Sandoz Inc., Teva Pharmaceutical Industries Ltd., Watson Laboratories, Inc.. (Gattuso, Dominick) |
| Jul 2, 2019 | 27 | Notice of Service (15) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents filed by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| Jul 1, 2019 | 26 | Scheduling Order (14) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 2/14/2020. Amended Pleadings due by 2/14/2020. Fact Discovery completed by 11/20/2020. Joint Claim Construction Brief due by 7/17/2020. A Markman Hearing is set for 8/18/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 9/10/2021, at 9:00 AM in Courtroom 6A. A 3-day Bench Trial is set to begin 10/4/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 6/28/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Jun 28, 2019 | 25 | Proposed Order (14) Docket Text: PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/28/2019 (nms). |
| Jun 26, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 6/26/2019. Local counsel present for plaintiff: D. Silver. Counsel present for defendants: A. Nelson, J. Jefferson, A. Ewing, A. Cheek, D. Abramowitz, K. Mowery, D. Silverstein, R. Vrana, Z. Cohen, R. Mosley, M. Becker, J. Seaman, G. Hache, J. Phillips. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00310-RGA et al.(crb) |
| Jun 25, 2019 | 24 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Aaron M. Nelson on behalf of Teva Pharmaceuticals USA, Inc. (Nelson, Aaron) |
| Jun 24, 2019 | 23 | Proposed Order (15) Docket Text: PROPOSED Scheduling Order, by Merck Sharp & Dohme Corp.. (Silver, Daniel) Modified on 6/24/2019 (nms). |
| Jun 19, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The conference scheduled for 6/26/2019, at 10:00 am will now be held in Courtroom 2B. Ordered by Judge Richard G. Andrews on 6/19/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Jun 5, 2019 | N/A | Order Setting Scheduling Conference (0) Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Wednesday, June 26, 2019, at 10:00 a.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiff's counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. The parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. Any requests or questions regarding the scheduling or management of this case shall be directed to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 6/5/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| May 21, 2019 | 20 | Answer to Counterclaim (10) Docket Text: ANSWER to [17] Answer to Complaint, Counterclaim by Merck Sharp & Dohme Corp..(Silver, Daniel) |
| May 2, 2019 | 19 | Redacted Document (3) Docket Text: REDACTED VERSION of [15] Stipulation and Order, by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 5/2/2019 (nms). |
| Apr 30, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Alexander S. Zolan for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Apr 30, 2019 | 17 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Merck Sharp & Dohme Corp., by Teva Pharmaceuticals USA, Inc..(Gattuso, Dominick) Modified on 5/1/2019 (nms). |
| Apr 30, 2019 | 18 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceuticals Industries, Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) |
| Apr 29, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (11 in 19-cv-320-RGA, 13 in 19-cv-312-RGA, 13 in 19-cv-311-RGA, 15 in 19-cv-314-RGA, 14 in 19-cv-318-RGA, 14 in 19-cv-347-RGA, 16 in 19-cv-313-RGA, 16 in 19-cv-310-RGA, 15 in 19-cv-317-RGA, 13 in 19-cv-321-RGA, 12 in 19-cv-316-RGA, 13 in 19-cv-319-RGA, 19 in 19-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 4/29/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Apr 29, 2019 | 14 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Alexander S. Zolan - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certification for Alexander S. Zolan)(Silver, Daniel) |
| Apr 29, 2019 | 14 | Certification for Alexander S. Zolan (1) |
| Apr 23, 2019 | 13 | Order (4) Docket Text: SO ORDERED re [12] Stipulation and Order (*Teva Pharmaceutical Industries Ltd. terminated). Signed by Judge Richard G. Andrews on 4/18/2019. (nms) |
| Apr 18, 2019 | 12 | Stipulation (5) Docket Text: STIPULATION Stipulation and [Proposed] Order to Remove Teva Ltd. as a Party by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) |
| Apr 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Julius Jefferson for Teva Pharmaceutical Industries Ltd.,for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Apr 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Keith A. Zullow for Teva Pharmaceutical Industries Ltd.,Keith A. Zullow for Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Apr 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christie Larochelle for Teva Pharmaceutical Industries Ltd. and Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
| Apr 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] Stipulation and Order to Extend Time (*Reset Answer Deadlines: Teva Pharmaceutical Industries Ltd. answer due 4/30/2019; Teva Pharmaceuticals USA, Inc. answer due 4/30/2019). Signed by Judge Richard G. Andrews on 4/12/2019. (nms) |
| Apr 12, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Keith A. Zullow, Emily L. Rapalino, Julius Jefferson, and Christie Larochelle, filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. Signed by Judge Richard G. Andrews on 4/12/2019. (nms) |
| Apr 12, 2019 | 9 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Dominick T. Gattuso on behalf of Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. (Gattuso, Dominick) |
| Apr 12, 2019 | 10 | Stipulation (2) Docket Text: STIPULATION and Order to Extend Time, by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) Modified on 4/12/2019 (nms). |
| Apr 12, 2019 | 11 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Keith A. Zullow, Emily L. Rapalino, Julius Jefferson, and Christie Larochelle - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Gattuso, Dominick) |
| Mar 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ddp) |
| Mar 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Mar 7, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Feb 22, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (6 in 19-cv-321-RGA, 6 in 19-cv-318-RGA, 6 in 19-cv-312-RGA, 6 in 19-cv-314-RGA, 6 in 19-cv-310-RGA, 6 in 19-cv-316-RGA, 6 in 19-cv-313-RGA, 6 in 19-cv-320-RGA, 6 in 19-cv-347-RGA, 6 in 1:19-cv-00319-RGA, 6 in 19-cv-317-RGA, 6 in 19-cv-311-RGA, 6 in 19-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jinyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/22/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) |
| Feb 21, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00310-UNA et al.(bkb) |
| Feb 21, 2019 | 6 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: # (1) Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). |
| Feb 21, 2019 | 6 | Certifications for Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, (6) |
| Feb 21, 2019 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Teva Pharmaceutical Industries Ltd. waiver sent on 2/15/2019, answer due 4/16/2019. (Silver, Daniel) |
| Feb 21, 2019 | 8 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Merck Sharp & Dohme Corp.: For Teva Pharmaceuticals USA, Inc. waiver sent on 2/15/2019, answer due 4/16/2019. (Silver, Daniel) |
| Feb 14, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 2/14/2019; Teva Pharmaceuticals USA, Inc. on 2/14/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Feb 13, 2019 | 1 | Exhibit A (17) |
| Feb 13, 2019 | 1 | Civil Cover Sheet (2) |
| Feb 13, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Feb 13, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/14/2010. Date of Expiration of Patent: 11/24/2026. (nmg) |
| Feb 13, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (nmg) |
| Feb 13, 2019 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (nmg) |
